New Contraceptives Like Yaz Increase Blood Clot Risks, FDA Study Finds
As FDA scientific panel prepares to meet in December, Simmons Law Firm says thousands still at risk St. Louis, MO (PRWEB) November 07, 2011 As reported by the Simmons Law Firm, women on birth control pills that contain the active ingredient drospirenone such as Yaz have a significantly higher risk of experiencing blood clots relative to other types of birth control, according to a new study released this past week by the Food & Drug Administration. The FDA study reviewed the medical history of more than 835,000 women who used birth control between January 2001 and December 2007. Durin
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4